As per the official notice, shortlisted candidates should submit their duly filled-in biodata and scanned copies of relevant ...

In the upcoming Jharkhand Assembly elections, the richest candidate, Aquil Akhtar, boasts a staggering ₹400 crore in assets, ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

Mavorixafor was generally well tolerated as a monotherapy and in combination with G-CSF, with no drug-related serious adverse ...

The Andhra Pradesh State Council of Higher Education (APSCHE) has already commenced the Phase 2 registration of the AP LAWCET ...

AP LAWCET counselling 2024 registration for phase 2 begins today. Eligible and interested candidates can register on the ...

Reserve Bank of India has declared RBI Grade B Result 2024. Candidates who have appeared for Officers in Grade ‘B’ (DR)- ...

X4 Pharmaceuticals ( (XFOR) ) has shared an announcement. X4 Pharmaceuticals has announced promising results from its Phase 2 trial of ...

The Reserve Bank of India has announced the 2024 RBI Grade B Results. Candidates who took the Grade "B" (DR)-General Phase 2 ...

In the EMPOWER trials, emraclidine was well-tolerated with a safety profile comparable to that observed in the Phase 1b trial. The most commonly reported adverse events in EMPOWER-1 and EMPOWER-2 ...

The next phase of the Downtown River Greenway is almost finished and the Sioux Falls Parks and Recreation is hosting a ribbon ...